US FDA approves first drug to treat fatty liver disease NASH


Reuters is first report The FDA approved Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug that treats a fatty liver disease called nonalcoholic steatohepatitis (NASH). This approval is the first of its kind.

market impact

The company’s shares surged 24% in after-hours trading.

Article tags

Topics of interest: healthy

type: Reuters Best

department: Pharmaceuticals and Healthcare

area: America

nation: USA

Winning type: speed

Story type: exclusive/exclusive report

media type: text

Customer Impact: important national stories

Source link

See also  Live video: Watch SpaceX launch intuitive machine Nova-C lunar lander

By Ali Raza

I am a dedicated and skilled News Content Writer with a passion for delivering accurate and engaging stories to a diverse audience. With a solid background in journalism and a keen eye for detail, I bring a commitment to excellence and a deep understanding of the evolving media landscape.

Leave a Reply

Your email address will not be published. Required fields are marked *